SARS Spike glycoprotein

Product Overview

SARS spike glycoprotein protein fragment

Nature

Recombinant

Tag/Conjugate

Unconjugated

Format

Liquid

Buffer

Preservative: 0.01% Sodium Azide Constituents: 50% Glycerol, 1.5M Urea, 25mM Tris HCl, 1mM EDTA

Preservative

0.01% Sodium Azide

Storage

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. Preservative: 0.01% Sodium Azide Constituents: 50% Glycerol, 1.5M Urea, 25mM Tris HCl, 1mM EDTA

Introduction

A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive stranded RNA approximately 27 to

Antigen Description

SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2.

Keywords

E2; E2 glycoprotein; Human coronavirus spike glycoprotein; Peplomer protein
S; S glycoprotein; Severe acute respiratory syndrome spike glycoprotein; Severe acute respiratory syndrome virus spike glycoprotein; Spike glycoprotein; VGL2; CoV spike glycoprote